Targeting ERBB Receptors in Cancer

作者: Nancy E. Hynes

DOI: 10.1007/978-3-540-31209-3_4

关键词:

摘要: Tyrosine kinases are a large and diverse family of proteins found only in metazoans. The ERBB family, which encompasses subgroup I the receptor tyrosine kinase (RTK) superfamily, has four members: epidermal growth factor (EGFR)/ErbB1, ErbB2, ErbB3, ErbB4. RTKs contain an extracellular domain that binds peptide ligands; they span membrane once have intracellular portion with protein activity (Fig. 4.1). Ligand binding induces formation dimers, as consequence intrinsic is activated transfers phosphate group from bound ATP to specific side chains on signaling bind active RTKs. Subsequently, multiple pathways become activated. receptor/ligand been investigated depth for many years, comprehensive maps describing links between plasma receptors, cytoplasmic pathways, nucleus available (Oda 2005).

参考文章(94)
Edward H Romond, Edith A Perez, John Bryant, Vera J Suman, Charles E Geyer Jr, Nancy E Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A Kaufman, Sandra M Swain, Thomas M Pisansky, Louis Fehrenbacher, Leila A Kutteh, Victor G Vogel, Daniel W Visscher, Greg Yothers, Robert B Jenkins, Ann M Brown, Shaker R Dakhil, Eleftherios P Mamounas, Wilma L Lingle, Pamela M Klein, James N Ingle, Norman Wolmark, None, Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer The New England Journal of Medicine. ,vol. 353, pp. 1673- 1684 ,(2005) , 10.1056/NEJMOA052122
Martine J. Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun-Shen Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas M. Suter, Josef Rüschoff, Tamás Sütő, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, M. Stella Dolci, Richard D. Gelber, Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer The New England Journal of Medicine. ,vol. 353, pp. 1659- 1672 ,(2005) , 10.1056/NEJMOA052306
Hiroko Ohgaki, Pierre Dessen, Benjamin Jourde, Sonja Horstmann, Tomofumi Nishikawa, Pier-Luigi Di Patre, Christoph Burkhard, Danielle Schüler, Nicole M. Probst-Hensch, Paulo César Maiorka, Nathalie Baeza, Paola Pisani, Yasuhiro Yonekawa, M. Gazi Yasargil, Urs M. Lütolf, Paul Kleihues, Genetic pathways to glioblastoma: a population-based study. Cancer Research. ,vol. 64, pp. 6892- 6899 ,(2004) , 10.1158/0008-5472.CAN-04-1337
Harold J. Burstein, Lyndsay N. Harris, Rebecca Gelman, Susan C. Lester, Raquel A. Nunes, Carolyn M. Kaelin, Leroy M. Parker, Leif W. Ellisen, Irene Kuter, Michele A. Gadd, Roger L. Christian, Patricia Rae Kennedy, Virginia F. Borges, Craig A. Bunnell, Jerry Younger, Barbara L. Smith, Eric P. Winer, Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study Journal of Clinical Oncology. ,vol. 21, pp. 46- 53 ,(2003) , 10.1200/JCO.2003.03.124
Bose S. Kochupurakkal, Daniel Harari, Ayelet Di-Segni, Galia Maik-Rachline, Ljuba Lyass, Gal Gur, Gabriele Kerber, Ami Citri, Sara Lavi, Raya Eilam, Vered Chalifa-Caspi, Zelig Eshhar, Eli Pikarsky, Ronit Pinkas-Kramarski, Sarah S. Bacus, Yosef Yarden, Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity Journal of Biological Chemistry. ,vol. 280, pp. 8503- 8512 ,(2005) , 10.1074/JBC.M413919200
Andrea B Motoyama, Nancy E Hynes, Heidi A Lane, None, The Efficacy of ErbB Receptor-targeted Anticancer Therapeutics Is Influenced by the Availability of Epidermal Growth Factor-related Peptides Cancer Research. ,vol. 62, pp. 3151- 3158 ,(2002)
Melody A. Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Susy Scholl, Louis Fehrenbacher, Janet M. Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon, Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease Journal of Clinical Oncology. ,vol. 17, pp. 2639- 2648 ,(1999) , 10.1200/JCO.1999.17.9.2639
Patrapim Sunpaweravong, Somkiat Sunpaweravong, Puttisak Puttawibul, Winyou Mitarnun, Chan Zeng, Anna E. Bar�n, Wilbur Franklin, Sherif Said, Marileila Varella-Garcia, Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma Journal of Cancer Research and Clinical Oncology. ,vol. 131, pp. 111- 119 ,(2005) , 10.1007/S00432-004-0610-7
Syed K. Mohsin, Heidi L. Weiss, M. Carolina Gutierrez, Gary C. Chamness, Rachel Schiff, Michael P. DiGiovanna, Chun-Xia Wang, Susan G. Hilsenbeck, C. Kent Osborne, D. Craig Allred, Richard Elledge, Jenny C. Chang, Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers Journal of Clinical Oncology. ,vol. 23, pp. 2460- 2468 ,(2005) , 10.1200/JCO.2005.00.661
Akira Funahashi, Yukiko Matsuoka, Kanae Oda, Hiroaki Kitano, A comprehensive pathway map of epidermal growth factor receptor signaling ,(2005)